Episode 63: Alex Cogdill, PhD, Director of Business Development and Corporate Strategy at Immunai

In this episode, Alex Cogdill joins us to discuss Immunai. Immunai is an innovative biotech company that works with partners to discover and develop therapies through the integration of machine learning and single-cell multimodal omics at scale. Dr. Cogdill has 13 years of experience in drug discovery and research management; having published >50 scientific articles in the immuno-oncology space with >9,000 citations

Learn more about Immunai here